November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE ... eluting bioresorbable scaffold for treating below-the-knee (BTK) peripheral ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

Although complications associated with peripheral vascular devices are typically minor, some infants may experience life-threatening sequelae or serious and prolonged alterations in function.

"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

Over 50% of these patients experience vascular access failures ... a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

Avinger Inc. ( (AVGR) ) has released its Q3 earnings. Here is a breakdown of the information Avinger Inc. presented to its investors. Avinger, ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Hello and welcome to BD’s Fourth Quarter and Full Year Fiscal ...

Over 90% of type 2 diabetes patients face an increased risk of heart disease due to high blood sugar's impact on blood ...